Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
BMC Infectious Diseases|January 17, 2023
Real-time analysis of hospital length of stay in a mixed SARS-CoV-2 Omicron and Delta epidemic in New South Wales, AustraliaRuarai J Tobin, James G Wood, Duleepa Jayasundara, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 4, 2015
Viremic and Virologically Suppressed HIV Infection Increases Age-Related Changes to Monocyte Activation Equivalent to 12 and 4 Years of Aging, RespectivelyThomas A Angelovich, Anna C Hearps, Anna Maisa, et al.
Plos One|February 1, 2013
Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected womenGenevieve E Martin, Maelenn Gouillou, Anna C Hearps, et al.
The Journal of Infectious Diseases|November 29, 2019
Levels of Human Immunodeficiency Virus DNA Are Determined Before ART Initiation and Linked to CD8 T-Cell Activation and Memory ExpansionGenevieve E Martin, Matthew Pace, Freya M Shearer, et al.
Plos Pathogens|July 15, 2016
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 InfectionMatthias Hoffmann, Nikos Pantazis, Genevieve E Martin, et al.
Mucosal Immunology|June 27, 2019
CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotypeJohn P Thornhill, Matthew Pace, Genevieve E Martin, et al.
Frontiers in Immunology|May 22, 2018
CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNAGenevieve E Martin, Matthew Pace, John P Thornhill, et al.
Frontiers in Immunology|June 21, 2021
Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral TherapyGenevieve E Martin, Debattama R Sen, Matthew Pace, et al.
Frontiers in Immunology|September 16, 2022
Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruptionMatthew Pace, Ane Ogbe, Jacob Hurst, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 20, 2020
Treatment of invasive IMP-4 Enterobacter cloacae infection in transplant recipients using ceftazidime/avibactam with aztreonam: A case series and literature reviewKelly A Cairns, Victoria Hall, Genevieve E Martin, et al.
Pageof 3